References
- Good JT Jr, King TE, Antony VB, et al. Lupus pleuritis: clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest 1983; 84(6): 714–8
- Hunder GG, McDuffie FC, Hepper NG. Pleural fluid complement in systemic lupus erythematosus and rheumatoid arthritis. Ann Intern Med 1972; 76(3): 357–63
- Halla JT, Schrohenloher RE, Volanakis JE. Immune complexes and other laboratory features of pleural effusions: a comparison of rheumatoid arthritis, systemic lupus erythematosus, and other diseases. Ann Intern Med 1980; 92(6):748–52
- Quismorio FP Jr. Clinical and pathologic features of lung involvement in systemic lupus erythematosus. Semin Respir Med 1988; 9(3): 297–304
- Wiedemann HP, Matthay RA. Pulmonary manifestations of the collagen vascular diseases. Clin Chest Med 1989; 10(4): 677–722
- Hnnninghake GW, Fauci AS. Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 1979; 119(3):471–503
- Carette S, Macher AM, Nussbaum A, et al. Severe, acute pulmonary disease in patients with systemic lupus erythematosus: ten years of experience at the National Institutes of Health. Semin Arthritis Rheum 1984; 14(1): 52–9
- Segal AM, Calabrese LH, Ahmad M, et al. The pulmonary manifestations of systemic lupus erythematosus. Semin Arthritis Rheum 1985;14(3): 202–24
- Millman RP, Cohen TB, Levinson AI, et al. Systemic lupus erythematosus complicated by acute pulmonary hemorrhage: recovery following plasmapheresis and cytotoxic therapy. (Letter) J Rheumatol 1981;8(6): 1021–3
- Matthay RA, Schwarz ML, Petty TL, et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 1974; 54(5):397–409
- Rubin LA, Urowitz MB. Shrinking lung syndrome in SLE: a clinical pathologic study. J Rheumatol 1983; 10(6): 973–6
- Asherson RA, Higenbottam TW, Dinh Xuan AT, et al. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 1990;17(10): 1292–8
- Mahowald ML, Weir EK, Ridley DJ, et al. Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics. J Rheumatol 1985; 12(4):773–7
- Simonson JS, Schiller NB, Petri M, et al. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1989; 16(7): 918–25
- Alpert MA, Pressly TA, Mukerji V, et al. Short-and long-term hemodynamic effects of Captopril in patients with pulmonary hypertension and selected connective tissue disease. Chest 1992; 102(5): 1407–12
- Baydur A, Mongan ES. Thoracic manifestations in rheumatoid arthritis. Semin Respir Med 1988;9(3):305–17
- Hull S, Mathews JA. Pulmonary necrobiotic nodules as a presenting feature of rheumatoid arthritis. Ann Rheum Dis 1982;41(1): 21–4
- Eraut D, Evans J, Caplin M. Pulmonary necrobiotic nodules without rheumatoid arthritis. Br J Dis Chest 1978; 72(4): 301–6
- Wallaert B, Hatron PY, Grosbois JM, et al. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage: relationship between alveolitis and subsequent changes in lung function. Am Rev Respir Dis 1986; 133(4): 574–80
- Hakala M, Paakko P, Sutinen S, et al. Association of bronchiolitis with connective tissue disorders. Ann Rheum Dis 1986; 45(8): 656–62
- Owens GR, Fbllansbee WR. Cardiopulmonary manifestations of systemic sclerosis. Chest 1987;91(1): 118–27
- Lomeo RM, Cornelia RJ, Schabet SI, et al. Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis. Am J Med 1989;87(5): 525–7
- Martinez-Lavin M, Vaughan JH, Tan EM. Autoantibodies and the spectrum of Sjögrens syndrome. Ann Intern Med 1979:91(2): 185–90
- Prakash UB. Pulmonary manifestations in mixed connective tissue disease. Semin Respir Med 1988;9(3): 318–24
- Wiener-Kronish JR Solinger AM, Warnock ML, et al. Severe pulmonary involvement in mixed connective tissue disease. Am Rev Respir Dis 1981; 124(4): 499–503